Literature DB >> 8241711

Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot.

J Karlsson1, B Diamant, H Theorell, K Folkers.   

Abstract

Ubiquinone (UQ) and alpha-tocopherol (AT) are two highly lipophilic antioxidants which can be dissolved only in lipid layers or attached to protein structures. Analyses of both UQ and AT in whole blood and plasma demonstrate identical values, which excludes any significant allocation to blood cells. The lipoidic plasma structures constitute the plasma lipoprotein fractions of high (HDL), low (LDL), and very low (VLDL) density in addition to chylomicrons. This means by definition that blood and plasma UQ and AT values are limited if not related to the lipoidic deposit volume. UQ and AT increase linearly with free cholesterol (FC). FC has therefore been suggested to be a good marker for the deposit volume. The ratios UQ and AT over FC--normalized UQ (N-UQ) and normalized AT (N-AT)--have been computed for inter- and intraindividual comparisons. With a plasma UQ content of 1 microgram/ml (approximately 1 mumol/l) and a plasma volume of 41, UQ makes up about 15% of the total heart content or under 1% of UQ in skeletal muscle. The corresponding value for the total extracellular UQ content is less than 2%. This means that extracellular UQ has no or a very minor role as a UQ depot. The same is true for AT. However, for transportation and allocation determinations of N-UQ and N-AT are relevant. Assuming only a lipoprotein-related transportation, healthy persons have saturated plasma UQ and AT values in only 25% and 10% of the population, respectively. All patient categories studied have been found nonsaturated. VLDL plus LDL constitute some 90% of the UQ deposit volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241711     DOI: 10.1007/bf00226846

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  16 in total

1.  Role of vitamin E in preventing the oxidation of low-density lipoprotein.

Authors:  H Esterbauer; M Dieber-Rotheneder; G Striegl; G Waeg
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

2.  Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions.

Authors:  K Johansen; H Theorell; J Karlsson; B Diamant; K Folkers
Journal:  Ann Med       Date:  1991-12       Impact factor: 4.709

3.  Determination of coenzyme Q10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection.

Authors:  P O Edlund
Journal:  J Chromatogr       Date:  1988-03-04

4.  Mitochondrial volume in skeletal muscle from young and old physically untrained and trained healthy men and from alcoholics.

Authors:  K H Kiessling; L Pilström; J Karlsson; K Piehl
Journal:  Clin Sci       Date:  1973-06       Impact factor: 6.124

Review 5.  On the antioxidant hypothesis with regard to arteriosclerosis.

Authors:  K F Gey
Journal:  Bibl Nutr Dieta       Date:  1986

6.  Lovastatin decreases coenzyme Q levels in humans.

Authors:  K Folkers; P Langsjoen; R Willis; P Richardson; L J Xia; C Q Ye; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Lovastatin decreases coenzyme Q levels in rats.

Authors:  R A Willis; K Folkers; J L Tucker; C Q Ye; L J Xia; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Human serum ubiquinol-10 levels and relationship to serum lipids.

Authors:  T Okamoto; T Matsuya; Y Fukunaga; T Kishi; T Yamagami
Journal:  Int J Vitam Nutr Res       Date:  1989       Impact factor: 1.784

9.  Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts.

Authors:  S Vadhanavikit; M Morishita; G A Duff; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

10.  Coenzyme Q10 content in different parts of the normal human heart.

Authors:  L Lin; P Sotonyi; E Somogyi; J Karlsson; K Folkers; Y Nara; C Sylvén; L Kaijser; E Jansson
Journal:  Clin Physiol       Date:  1988-08
View more
  4 in total

1.  Vitamins Q and E, extracorporal circulation and hemolysis.

Authors:  J Karlsson; R Ronneberg; B Semb
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

Review 2.  HDL and cholesterol: life after the divorce?

Authors:  Kasey C Vickers; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-19       Impact factor: 5.922

3.  Antioxidative capacity in patients with common variable immunodeficiency.

Authors:  J Reichenbach; R Schubert; C Schwan; K Müller; H J Böhles; S Zielen
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

4.  Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

Authors:  Beatrice A Golomb; Edwin K Kwon; Sabrina Koperski; Marcella A Evans
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.